Literature DB >> 33561620

Multifactorial barriers in the implementation of schizophrenia and psychosocial therapies guidelines: A quantitative study across different professions.

Gabriele Gaigl1, Esther Täumer2, Katharina Merz2, Sabina Zöscher2, Sarah Wagner2, Markus Kösters3, Peter Falkai2, Stefan Leucht4, Alkomiet Hasan5.   

Abstract

BACKGROUND: Clinical guidelines can facilitate the transfer of scientific evidence into clinical practice, yet their implementation still faces difficulties. The aim of this study was to examine the implementation status of the current German evidence- and consensus-based guidelines for schizophrenia (2019) and psychosocial therapies (2019) and to identify barriers as well as facilitators in guideline adherence.
METHODS: We used a quantitative approach by developing an online questionnaire, focusing on the current implementation status as well as barriers and facilitators in guideline adherence. The questionnaire was sent to 100 hospitals for psychiatry and psychosomatics and 52 professional associations in mental healthcare in Germany (investigation period: 10/2019-01/2020).
RESULTS: In total, 657 mental healthcare professionals (MHCP, e.g. medical doctors, psychologists, psychosocial therapists, caregivers) provided sufficient responses for analyses. Less than half (47%) of our participants were aware of the existence of the guideline for psychosocial therapies, while 74% exhibited awareness of the schizophrenia guideline. A minority reported to adhere to the current guidelines for schizophrenia (41%) and psychosocial interventions (18%). Profession-related differences in the implementation-status were detected. Specifically, medical doctors exhibited higher awareness rates than psychosocial therapists and caregivers and additionally higher adherence rates than psychologists and caregivers. Medical doctors were less exposed to knowledge-related barriers (e.g. lack of guideline familiarity), while no differences across professions were found in external/behavior-related barriers (e.g. long versions). DISCUSSION AND
CONCLUSION: Our findings indicate that the implementation of guidelines as well as related barriers vary between professions. To prevent a growing gap in guideline adherence between MHCP, target-specific implementation strategies should be considered.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Barrier; Guideline; Implementation; Profession; Psychosocial therapies; Schizophrenia

Year:  2021        PMID: 33561620     DOI: 10.1016/j.schres.2021.01.010

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  2 in total

1.  Structured implementation of digital, systematically updated guideline recommendations for enhanced adherence in schizophrenia (SISYPHOS)-protocol of a cluster-randomized trial.

Authors:  Alkomiet Hasan; Stefan Leucht; Carolin Lorenz; Gabriele Gaigl; Duygu Güler; Theresa Halms; Naiiri Khorikian-Ghazari; Astrid Röh; Marco Schneider; Elias Wagner; Thomas Schneider-Axmann; Angelika Kapfhammer; Marisa Flick; Charline Pielenz; Eva Salveridou-Hof; Peter Falkai; Wolfgang Gaebel
Journal:  Trials       Date:  2022-09-24       Impact factor: 2.728

2.  Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.

Authors:  Shusuke Numata; Masahito Nakataki; Naomi Hasegawa; Yoshikazu Takaesu; Masahiro Takeshima; Toshiaki Onitsuka; Toshinori Nakamura; Reon Edagawa; Hiroaki Edo; Kenichiro Miura; Junya Matsumoto; Norio Yasui-Furukori; Taishiro Kishimoto; Hikaru Hori; Takashi Tsuboi; Yuka Yasuda; Ryuji Furihata; Hiroyuki Muraoka; Shinichiro Ochi; Tatsuya Nagasawa; Yoshitaka Kyou; Atsunobu Murata; Eiichi Katsumoto; Kazutaka Ohi; Akitoyo Hishimoto; Ken Inada; Koichiro Watanabe; Ryota Hashimoto
Journal:  Neuropsychopharmacol Rep       Date:  2021-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.